A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in Uganda

about

A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in Uganda

P2860

Q56910972-611E381E-D1F8-47C4-BDDA-C5F0C5F3D0AB

P2860

A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in Uganda

Item

http://www.wikidata.org/entity/Q56912008

description

article

@en

im Juni 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2018

@uk

name

A Prospective Evaluation of a ...... ogram in HIV Clinics in Uganda

@en

A Prospective Evaluation of a ...... ogram in HIV Clinics in Uganda

@nl

type

Item

label

A Prospective Evaluation of a ...... ogram in HIV Clinics in Uganda

@en

A Prospective Evaluation of a ...... ogram in HIV Clinics in Uganda

@nl

prefLabel

A Prospective Evaluation of a ...... ogram in HIV Clinics in Uganda

@en

A Prospective Evaluation of a ...... ogram in HIV Clinics in Uganda

@nl

P1476

A Prospective Evaluation of a ...... ogram in HIV Clinics in Uganda

@en

P2093

David B Meya

http://www.w3.org/2001/XMLSchema#string

Elizabeth Nalintya

http://www.w3.org/2001/XMLSchema#string

Kathy Huppler Hullsiek

http://www.w3.org/2001/XMLSchema#string

Radha Rajasingham

http://www.w3.org/2001/XMLSchema#string

Sarah Lofgren

http://www.w3.org/2001/XMLSchema#string

P2860

Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings

Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.

Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda.

Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality.

Implementation and Operational Research: Evaluation of a Public-Sector, Provider-Initiated Cryptococcal Antigen Screening and Treatment Program, Western Cape, South Africa

The impact of routine cryptococcal antigen screening on survival among HIV-infected individuals with advanced immunosuppression in Kenya

Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.

Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.

Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.

Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.

P304

231-238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0000000000001669

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David R. Boulware

P577

2018-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29509588

http://www.w3.org/2001/XMLSchema#string

P921

Uganda

P932

5953806

http://www.w3.org/2001/XMLSchema#string

A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in Uganda

about

P2860

P2860

A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in Uganda

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932